Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nakata, Y. Kotani, Y. Hatakeyama, N. Tomita, N. Hazeki, A. Sakashita, K. Kobayashi, Y. Funada, Y. Nishimura (Kobe, Japan). Clinical utility of EGFR gene mutation analysis with cytological materials from bronchoscopy not histological materials. Eur Respir J 2011; 38: Suppl. 55, 1977

Member's Comments

No comment yet.

Related content which might interest you: Feasibility of EGFR mutation testing on EBUS-TBNA and bronchial biopsy samples obtained during routine practice Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 The detection of EGFR mutations in liquid biopsy by allele-specific qPCR – the comparative evaluation of two common diagnostic tests Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Performance of ROS1 fusion gene test using FFPE tissue and bronchoscopic cytologic specimen Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Does immediate cytological analysis at bronchoscopy lead to reduced number of biopsies? Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Development and clinical testing of a device for functional bronchoscopy Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play Year: 2011 EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 IFIGENIA-study: methods, patient characteristics and diagnostic confirmation by independent HRCT and histology committees Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002 EGFR and KRAS mutational profiling in NSCLC cells obtained through fine needle aspiration cytology (FNAC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Diagnostic yield of bronchoscopic procedures in lung cancer according to histological cell type Source: Eur Respir J 2001; 18: Suppl. 33, 61s Year: 2001 How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC? Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 The impact of rapid on site evaluation of cytological specimens on a new endobronchial ultrasound (EBUS) service Source: Annual Congress 2011 - Are needles really enough? Year: 2011 Detection of k-ras mutations in cytologic specimen of lung cancer patients as predictive factor of targeted therapy Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients Source: Eur Respir J 2012; 40: 267-269 Year: 2012 Comparative biochemical and cytological activity markers according to the radiographic pattern in patients with newly diagnosed sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007 Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Source: Eur Respir J 2001; 18: Suppl. 33, 326s Year: 2001 The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011